Project organization: AstraZeneca

Development of Small Molecule Formulations for Enhanced Production of CAR-T Cell Therapies

Automation and Control of a Precipitation-based Continuous Downstream Process for High Titer Products

Development of an Interoperable Module and Novel Mathematical Framework for Modeling pH Dynamics Across Chromatography Modalities

Preventive Medical Countermeasures PROGRAM

PI – Rapid Micro: novel methods and control strategy

PI – Sustainability Modeling

Next-generation Factory Business & Data Mapping

Next Gen High Level Design of Facility Layout

Protein A Chromatography Multi-scale Data Driven/Mechanistic Modeling (Phase 2)

A Fully Continuous Downstream Process for High Titer Products

Cell Culture Glycosylation Multi-scale Data Driven Mechanistic Modeling (Phase 2)

N-mAb